We estimate that the CEO of Syndax Pharmaceuticals Inc ($SNDX), Michael A. Metzger, received a compensation of $7,089,213 in 2025. This is a decrease of -8.72% from an estimated $7,707,176 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 30, 2026. Note that parsing errors may occur.
You can track $SNDX on Quiver Quantitative's $SNDX stock dashboard.
$SNDX Stock Insider Trading Activity
$SNDX Stock insiders have traded $SNDX stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $SNDX stock by insiders over the last 6 months:
- MICHAEL A METZGER (Chief Executive Officer) has made 0 purchases and 2 sales selling 24,571 shares for an estimated $513,654.
- KEITH A. GOLDAN (Chief Financial Officer) has made 0 purchases and 2 sales selling 5,492 shares for an estimated $114,636.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$SNDX Stock Hedge Fund Activity
We have seen 109 institutional investors add shares of $SNDX Stock stock to their portfolio, and 115 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HOOD RIVER CAPITAL MANAGEMENT LLC added 2,316,553 shares (+inf%) to their portfolio in Q4 2025, for an estimated $48,670,778
- VANGUARD GROUP INC added 1,091,717 shares (+21.2%) to their portfolio in Q4 2025, for an estimated $22,936,974
- BANK OF AMERICA CORP /DE/ added 1,012,993 shares (+27.4%) to their portfolio in Q4 2025, for an estimated $21,282,982
- MILLENNIUM MANAGEMENT LLC removed 994,519 shares (-95.0%) from their portfolio in Q4 2025, for an estimated $20,894,844
- UBS GROUP AG removed 958,294 shares (-57.2%) from their portfolio in Q4 2025, for an estimated $20,133,756
- QUBE RESEARCH & TECHNOLOGIES LTD removed 956,707 shares (-58.2%) from their portfolio in Q4 2025, for an estimated $20,100,414
- ENSIGN PEAK ADVISORS, INC added 789,480 shares (+97.6%) to their portfolio in Q4 2025, for an estimated $16,586,974
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$SNDX Stock Analyst Ratings
Wall Street analysts have issued reports on $SNDX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 12/09/2025
- Barclays issued a "Overweight" rating on 11/24/2025
To track analyst ratings and price targets for $SNDX Stock, check out Quiver Quantitative's $SNDX forecast page.
$SNDX Stock Price Targets
Multiple analysts have issued price targets for $SNDX recently. We have seen 10 analysts offer price targets for $SNDX in the last 6 months, with a median target of $41.5.
Here are some recent targets:
- Etzer Darout from Barclays set a target price of $37.0 on 05/01/2026
- Corinne Johnson from Goldman Sachs set a target price of $34.0 on 04/01/2026
- Salim Syed from Mizuho set a target price of $43.0 on 03/31/2026
- Faisal Khurshid from Jefferies set a target price of $40.0 on 03/30/2026
- Anupam Rama from JP Morgan set a target price of $45.0 on 03/09/2026
- Yigal Nochomovitz from Citigroup set a target price of $57.0 on 03/02/2026
- Justin Zelin from BTIG set a target price of $56.0 on 12/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
